News Focus
News Focus
Followers 195
Posts 33292
Boards Moderated 1
Alias Born 03/27/2009

Re: None

Monday, 02/25/2013 10:36:49 AM

Monday, February 25, 2013 10:36:49 AM

Post# of 2804248
Compensated Awareness Post View Disclaimer
$RBCC Press Releases

Press Releases Get Press Releases for:
Filter Headlines
Wednesday, February 13, 2013

RBCC Retains New IR Group to Optimize Investor Outreach, Relay Key Growth PlansBusiness Wire( (Wed, Feb 13)
Wednesday, February 6, 2013

RBCC: n3D Technology Could Lead to Lab-Grown Implantable OrgansBusiness Wire( (Wed, Feb 6)
Wednesday, January 30, 2013

RBCC Partner N3D Could Revolutionize Toxicity TestingBusiness Wire( (Wed, Jan 30)
Tuesday, January 22, 2013

RBCC Visits Texas Genome-Mapping TargetBusiness Wire( (Tue, Jan 22)
Monday, January 14, 2013

RBCC Explores ‘Target-Rich Environment’ as Biotechnology Takes Over San FranciscoBusiness Wire( (Mon, Jan 14)
Tuesday, January 8, 2013

RBCC Seeks Out New Breakthroughs at Biotech Showcase 2013Business Wire( (Tue, Jan 8)
Wednesday, December 19, 2012

RBCC’s Pending JV Partner Amarantus Licenses Alzheimer’s Blood Test BreakthroughBusiness Wire( (Wed, Dec 19)
Wednesday, December 5, 2012

RBCC Target Amarantus Wins MANF Patent Challenge in EuropeBusiness Wire( (Wed, Dec 5)
Monday, December 3, 2012

RBCC Issues Shareholder Letter Celebrating Promising 2013Business Wire( (Mon, Dec 3)
Thursday, November 29, 2012

RBCC JV Target Amarantus Presents Parkinson’s Therapeutic at CNS SummitBusiness Wire( (Thu, Nov 29)
Monday, November 26, 2012

RBCC JV Target Amarantus Explores Orphan Drug Designation for MANFBusiness Wire( (Mon, Nov 26)
Monday, November 19, 2012

RBCC: Short R&D Timeline Could Lead to Larger ProfitsBusiness Wire( (Mon, Nov 19)
Thursday, November 15, 2012

RBCC JV Target Amarantus Secures $1.1 Million in FinancingBusiness Wire( (Thu, Nov 15)

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now